BridgeMD
New treatment option for Hypertension
Official title OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
ClinicalTrials.gov ID: NCT05293756
What this study is testing
- What it's testing
- Hypertension (HTN) has a greater impact on African Americans (AA) than any other U.S. racial group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 and older
You may be able to join if
- Self-identify as African American
- 50 years of age or older
- Diagnosed with hypertension, with a systolic blood pressure≥ 130 mmHg but less than 170 mmHg
- Prescribed at least two hypertensive, one of which is a diuretic/thiazide and or calcium channel blocker antihypertensive medication
- Own a smartphone with a data plan, the capability to download the Medisafe app, or view videos
You likely can't join if
- Unable to give informed consent or judged to have impaired cognitive ability or severe memory
- Currently using a medication management application (app)
- Experienced a major CVD event or procedure (e.g., myocardial infarction, stroke, heart surgery) within the past year
- Patients with a diagnosis of chronic kidney disease (defined as estimated glomerular filtration rate (eGFR) \< 60 ml/min/1.73m2) and/or receiving...
See the full eligibility criteria
- Self-identify as African American
- 50 years of age or older
- Diagnosed with hypertension, with a systolic blood pressure≥ 130 mmHg but less than 170 mmHg
- Prescribed at least two hypertensive, one of which is a diuretic/thiazide and or calcium channel blocker antihypertensive medication
- Own a smartphone with a data plan, the capability to download the Medisafe app, or view videos
- Able to read/understand English
- Unable to give informed consent or judged to have impaired cognitive ability or severe memory
- Currently using a medication management application (app)
- Experienced a major CVD event or procedure (e.g., myocardial infarction, stroke, heart surgery) within the past year
- Patients with a diagnosis of chronic kidney disease (defined as estimated glomerular filtration rate (eGFR) \< 60 ml/min/1.73m2) and/or receiving dialysis.
The study team makes the final eligibility decision.
Where it's taking place
- Cleveland, Ohio, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cleveland, Ohio, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.